Public-registry site landscape for NCT07712913, a Diabetic Neuropathy study sponsored by Brainfarma Industria Química e Farmacêutica S/A. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07712913 (registry record) |
| Sponsor | Brainfarma Industria Química e Farmacêutica S/A |
| Condition(s) | Diabetic Neuropathy; Neuropathic Pain; Neuralgia, Postherpetic |
| Phase | PHASE3 |
| Listed sites | 15 |
| Site countries | Brazil |
Eichor generates a preliminary site-risk snapshot for NCT07712913 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →